Trial Profile

Amlodipine/valsartan versus maximum-dose losartan in hypertensive patients also receiving hydrochlorothiazide

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 11 Jun 2011

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Amlodipine/valsartan (Primary) ; Hydrochlorothiazide; Losartan
Indications Hypertension
Focus Therapeutic Use
Sponsors Novartis Pharmaceuticals Corporation

Most Recent Events

11 Jun 2011 New trial record
24 May 2011 Results presented at the 26th Annual Scientific Meeting of the American Society of Hypertension.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com